General Information
DRAVP ID DRAVPe01595
Peptide Name NS5A-derived peptide C5A [I10S]
Sequence SWLRDIWDWSCEVLSDFK
Sequence Length 18
UniProt ID V5RF15
Source Synthetic construct
Activity Information
Target Organism HCV,HIV
Assay Pseudotyped HIV (HIVpp) and antiviral assay,HCV production and infection assay
Activity
Hemolytic Activity
Cytotoxicity
Binding Target membrane
Mechanism The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe01595
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C106H149N25O30S
Absent amino acids AGHMNPQTY
Common amino acids DSW
Mass 2285.56
Pl 4.23
Basic residues 2
Acidic residues 4
Hydrophobic residues 8
Net charge -2
Boman Index -3359
Hydrophobicity -32.78
Aliphatic Index 81.11
Half Life
Extinction Coefficient cystines 16500
Absorbance 280nm 970.59
Polar residues 4
Literature Information
Literature 1
Title Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.
Pubmed ID 21801309
Reference Chem Biol Drug Des. 2011 Nov;78(5):835-43.
Author Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX.